NOVEL HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
The present invention provides novel compounds having a P2X 3 and/or P2X 2/3 receptor antagonistic effect. A pharmaceutical composition having a P2X 3 and/or P2X 2/3 receptor antagonistic effect comprising a compound of the formula (I): wherein ring A is substituted or unsubstituted 5 to 7-membered...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
19.06.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides novel compounds having a P2X 3 and/or P2X 2/3 receptor antagonistic effect. A pharmaceutical composition having a P2X 3 and/or P2X 2/3 receptor antagonistic effect comprising a compound of the formula (I):
wherein
ring A is substituted or unsubstituted 5 to 7-membered cycloalkane, substituted or unsubstituted 5 to 7-membered cycloalkene or the like;
C is a carbon atom;
-X- is -N(R 16 )- or the like;
R 16 is hydrogen, substituted or unsubstituted alkyl or the like;
R 7 is substituted or unsubstituted 5- or 6-membered heteroaryl, substituted or unsubstituted 6 to 10 membered aryl;
Q 1 and Q 2 are each independently a carbon atom or a nitrogen atom;
-L- is -O-, -S- or the like;
R 6 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl or the like;
R 2 is hydrogen, hydroxy or the like,
or its pharmaceutically acceptable salt or a solvate thereof. |
---|---|
Bibliography: | Application Number: EP20110816406 |